Association between circulating fibroblast growth factor 21 and mortality in end-stage renal disease
出版年份 2017 全文链接
标题
Association between circulating fibroblast growth factor 21 and mortality in end-stage renal disease
作者
关键词
Chronic kidney disease, Death rates, Fibroblast growth factor, Medical dialysis, Diabetes mellitus, Brain natriuretic peptide, Insulin, Renal system
出版物
PLoS One
Volume 12, Issue 6, Pages e0178971
出版商
Public Library of Science (PLoS)
发表日期
2017-06-06
DOI
10.1371/journal.pone.0178971
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Fibroblast growth factor 21 and its novel association with oxidative stress
- (2017) Miguel Ángel Gómez-Sámano et al. Redox Biology
- Development of a new risk model for predicting cardiovascular events among hemodialysis patients: Population-based hemodialysis patients from the Japan Dialysis Outcome and Practice Patterns Study (J-DOPPS)
- (2017) Yukiko Matsubara et al. PLoS One
- Association Between Serum Fibroblast Growth Factor 21 and Mortality Among Patients With Coronary Artery Disease
- (2016) Qing Li et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Endurance Exercise Reduces Hepatic Fat Content and Serum Fibroblast Growth Factor 21 Levels in Elderly Men
- (2016) Hirokazu Taniguchi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Circulating Fibroblast Growth Factor 21 Is A Sensitive Biomarker for Severe Ischemia/reperfusion Injury in Patients with Liver Transplantation
- (2016) Dewei Ye et al. Scientific Reports
- Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases
- (2016) Peng Cheng et al. Journal of Diabetes Research
- Fibroblast Growth Factor 21 (FGF-21) in Peritoneal Dialysis Patients: Natural History and Metabolic Implications
- (2016) Elena González et al. PLoS One
- Circulating Fibroblast Growth Factor 21 Levels Predict Progressive Kidney Disease in Subjects With Type 2 Diabetes and Normoalbuminuria
- (2015) C. H. Lee et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- FGF21 Response to Critical Illness: Effect of Blood Glucose Control and Relation With Cellular Stress and Survival
- (2015) Steven E. Thiessen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Blood glucose fluctuations in hemodialysis patients with end stage diabetic nephropathy
- (2015) Yue-ping Jin et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Biomarkers of rapid chronic kidney disease progression in type 2 diabetes
- (2015) Helen C. Looker et al. KIDNEY INTERNATIONAL
- Development and validation of a predictive mortality risk score from a European hemodialysis cohort
- (2015) Jürgen Floege et al. KIDNEY INTERNATIONAL
- Association between Serum Soluble Klotho Levels and Mortality in Chronic Hemodialysis Patients
- (2015) Naoko Otani-Takei et al. International Journal of Endocrinology
- The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study
- (2014) Kwok-Leung Ong et al. DIABETOLOGIA
- Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1α-mediated antioxidant capacity in mice
- (2014) Dewei Ye et al. HEPATOLOGY
- Novel Insights into the Cardio-Protective Effects of FGF21 in Lean and Obese Rat Hearts
- (2014) Vanlata Patel et al. PLoS One
- FGF21 as a Stress Hormone: The Roles of FGF21 in Stress Adaptation and the Treatment of Metabolic Diseases
- (2014) Kook Hwan Kim et al. Diabetes & Metabolism Journal
- Activation of Liver FGF21 in hepatocarcinogenesis and during hepatic stress
- (2013) Chaofeng Yang et al. BMC GASTROENTEROLOGY
- The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
- (2013) Gregory Gaich et al. Cell Metabolism
- Serum levels of fibroblast growth factor-21 are increased in chronic and acute renal dysfunction
- (2013) Janka Hindricks et al. CLINICAL ENDOCRINOLOGY
- Serum fibroblast growth factor 21 is predictive of combined cardiovascular morbidity and mortality in patients with type 2 diabetes at a relatively short-term follow-up
- (2013) M. Lenart-Lipińska et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Fibroblast growth factor 21 protects against cardiac hypertrophy in mice
- (2013) A. Planavila et al. Nature Communications
- Endocrine Protection of Ischemic Myocardium by FGF21 from the Liver and Adipose Tissue
- (2013) Shu Q. Liu et al. Scientific Reports
- Increased FGF21 plasma levels in humans with sepsis and SIRS
- (2013) Karim Gariani et al. Endocrine Connections
- Cardioprotective proteins upregulated in the liver in response to experimental myocardial ischemia
- (2012) Shu Q. Liu et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- MECHANISMS IN ENDOCRINOLOGY: Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21
- (2012) Pedro Iglesias et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Serum Fibroblast Growth Factor 21 Is Associated with Renal Function and Chronic Kidney Disease in Community-Dwelling Adults
- (2012) Candace Crasto et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Executive Summary: Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
- (2011) D. B. Sacks et al. CLINICAL CHEMISTRY
- Sleep-disordered breathing predicts cardiovascular events and mortality in hemodialysis patients
- (2011) T. Masuda et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Circulating FGF21 Levels Are Progressively Increased from the Early to End Stages of Chronic Kidney Diseases and Are Associated with Renal Function in Chinese
- (2011) Zhuofeng Lin et al. PLoS One
- Serum fibroblast growth factor–21 concentration is associated with residual renal function and insulin resistance in end-stage renal disease patients receiving long-term peritoneal dialysis
- (2010) Seung Hyeok Han et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus
- (2010) et al. Journal of Diabetes Investigation
- Circulating Fibroblast Growth Factor-21 Is Elevated in Impaired Glucose Tolerance and Type 2 Diabetes and Correlates With Muscle and Hepatic Insulin Resistance
- (2009) A. O. Chavez et al. DIABETES CARE
- Fibroblast Growth Factor 21 Reduces the Severity of Cerulein-Induced Pancreatitis in Mice
- (2009) Charis L. Johnson et al. GASTROENTEROLOGY
- Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans
- (2008) X. Zhang et al. DIABETES
- Serum Levels of the Adipokine FGF21 Depend on Renal Function
- (2008) S. Stein et al. DIABETES CARE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search